Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Hiv en COVID-19: risicofactoren voor ernstige ziekte
feb 2021 | HIV, Virale infecties